Source comparison
Best KPV Dosage for Gut Health: Comparison by Inflammation Severity
Mild (calprotectin 50–150 mcg/g, no ulceration) 250–300mcg daily Once daily subcutaneous, morning 8–12 weeks minimum 10–14 days for symptom reduction; 6–8 weeks for biomarker normalisation Effective for maintenance and prevention. Not aggressive enough for act
This comparison does not assign a generated winner or score.
- Mild (calprotectin 50–150 mcg/g, no ulceration)
- 250–300mcg daily
- Once daily subcutaneous, morning
- 8–12 weeks minimum
- 10–14 days for symptom reduction; 6–8 weeks for biomarker normalisation
- Effective for maintenance and prevention. Not aggressive enough for active flares
- Moderate (calprotectin 150–400 mcg/g, mild ulceration)
- 350–450mcg daily
- Once daily or split into 175–225mcg twice daily
- 12–16 weeks minimum
- 7–10 days for symptom reduction; 8–12 weeks for mucosal healing
- Optimal balance of efficacy and receptor sustainability. Most research protocols use this range
- Severe (calprotectin >400 mcg/g, active ulceration or fistulising disease)
- 500mcg daily
- Split into 250mcg twice daily (morning and evening)
- 16–24 weeks minimum
- 5–7 days for symptom reduction; 12–16 weeks for endoscopic improvement
- Maximum effective dose. Higher doses do not increase efficacy and risk receptor downregulation
- Maintenance (post-remission, calprotectin <50 mcg/g)
- 150–250mcg daily
- Indefinite or until protocol adjustment
- Maintains remission without tolerance buildup
- Lower bound of therapeutic range. Sufficient to prevent relapse without chronic high-dose exposure